These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A Systematic Evaluation of Antibody Modification and Sharma SK; Glaser JM; Edwards KJ; Khozeimeh Sarbisheh E; Salih AK; Lewis JS; Price EW Bioconjug Chem; 2021 Jul; 32(7):1177-1191. PubMed ID: 32197571 [TBL] [Abstract][Full Text] [Related]
6. Cadherin-17 as a target for the immunoPET of adenocarcinoma. Delaney S; Keinänen O; Lam D; Wolfe AL; Hamakubo T; Zeglis BM Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2547-2557. PubMed ID: 38625402 [TBL] [Abstract][Full Text] [Related]
7. DFO-Km: A Modular Chelator as a New Chemical Tool for the Construction of Zirconium-89-Based Radiopharmaceuticals. Salih AK; Dominguez Garcia M; Raheem SJ; Ahiahonu WK; Price EW Inorg Chem; 2023 Dec; 62(50):20806-20819. PubMed ID: 37751491 [TBL] [Abstract][Full Text] [Related]
10. Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for Raavé R; Sandker G; Adumeau P; Jacobsen CB; Mangin F; Meyer M; Moreau M; Bernhard C; Da Costa L; Dubois A; Goncalves V; Gustafsson M; Rijpkema M; Boerman O; Chambron JC; Heskamp S; Denat F Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1966-1977. PubMed ID: 31161258 [TBL] [Abstract][Full Text] [Related]
11. [ Lu Y; Li M; Massicano AVF; Song PN; Mansur A; Heinzman KA; Larimer BM; Lapi SE; Sorace AG Molecules; 2021 Mar; 26(6):. PubMed ID: 33809310 [TBL] [Abstract][Full Text] [Related]
12. Bioorthogonal Fluorophore Linked DFO-Technology Enabling Facile Chelator Quantification and Multimodal Imaging of Antibodies. Meimetis LG; Boros E; Carlson JC; Ran C; Caravan P; Weissleder R Bioconjug Chem; 2016 Jan; 27(1):257-63. PubMed ID: 26684717 [TBL] [Abstract][Full Text] [Related]
13. ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor Xenografts. Cheal SM; Ruan S; Veach DR; Longo VA; Punzalan BJ; Wu J; Fung EK; Kelly MP; Kirshner JR; Giurleo JT; Ehrlich G; Han AQ; Thurston G; Olson WC; Zanzonico PB; Larson SM; Carrasquillo JA Mol Pharm; 2018 Jun; 15(6):2133-2141. PubMed ID: 29684277 [TBL] [Abstract][Full Text] [Related]
14. Site-Specific Yue TTC; Ge Y; Aprile FA; Ma MT; Pham TT; Long NJ Bioconjug Chem; 2023 Oct; 34(10):1802-1810. PubMed ID: 37751398 [TBL] [Abstract][Full Text] [Related]
15. First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using Ulaner GA; Lyashchenko SK; Riedl C; Ruan S; Zanzonico PB; Lake D; Jhaveri K; Zeglis B; Lewis JS; O'Donoghue JA J Nucl Med; 2018 Jun; 59(6):900-906. PubMed ID: 29146695 [TBL] [Abstract][Full Text] [Related]
16. Development and in vitro evaluation of new bifunctional Klasen B; Lemcke D; Mindt TL; Gasser G; Rösch F Nucl Med Biol; 2021; 102-103():12-23. PubMed ID: 34242949 [TBL] [Abstract][Full Text] [Related]
18. Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3-Expressing Liver Cancer by Immuno-PET. Fayn S; King AP; Gutsche NT; Duan Z; Buffington J; Olkowski CP; Fu Y; Hong J; Sail D; Baidoo KE; Swenson RE; Cheloha RW; Ho M; Choyke PL; Escorcia FE J Nucl Med; 2023 Jul; 64(7):1017-1023. PubMed ID: 36997331 [TBL] [Abstract][Full Text] [Related]
19. Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours. Knight JC; Mosley MJ; Kersemans V; Dias GM; Allen PD; Smart S; Cornelissen B Nucl Med Biol; 2019 Mar; 70():14-22. PubMed ID: 30825614 [TBL] [Abstract][Full Text] [Related]
20. Immuno-PET imaging of tumor endothelial marker 8 (TEM8). Kuo F; Histed S; Xu B; Bhadrasetty V; Szajek LP; Williams MR; Wong K; Wu H; Lane K; Coble V; Vasalatiy O; Griffiths GL; Paik CH; Elbuluk O; Szot C; Chaudhary A; St Croix B; Choyke P; Jagoda EM Mol Pharm; 2014 Nov; 11(11):3996-4006. PubMed ID: 24984190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]